nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP3A4—breast cancer	0.235	1	CbGaD
Esomeprazole—CYP2C19—Lapatinib—breast cancer	0.0493	0.115	CbGbCtD
Esomeprazole—CYP3A4—Exemestane—breast cancer	0.0472	0.11	CbGbCtD
Esomeprazole—CYP3A4—Letrozole—breast cancer	0.0401	0.0935	CbGbCtD
Esomeprazole—CYP3A4—Anastrozole—breast cancer	0.0358	0.0833	CbGbCtD
Esomeprazole—CYP3A4—Toremifene—breast cancer	0.0327	0.0762	CbGbCtD
Esomeprazole—CYP3A4—Fulvestrant—breast cancer	0.0304	0.0708	CbGbCtD
Esomeprazole—CYP3A4—Thiotepa—breast cancer	0.0271	0.0631	CbGbCtD
Esomeprazole—CYP3A4—Ixabepilone—breast cancer	0.0248	0.0577	CbGbCtD
Esomeprazole—CYP2C19—Tamoxifen—breast cancer	0.0247	0.0576	CbGbCtD
Esomeprazole—CYP3A4—Lapatinib—breast cancer	0.0239	0.0556	CbGbCtD
Esomeprazole—CYP3A4—Raloxifene—breast cancer	0.0181	0.0421	CbGbCtD
Esomeprazole—CYP3A4—Vinorelbine—breast cancer	0.0132	0.0308	CbGbCtD
Esomeprazole—CYP3A4—Tamoxifen—breast cancer	0.0119	0.0278	CbGbCtD
Esomeprazole—CYP3A4—Mitoxantrone—breast cancer	0.0116	0.0271	CbGbCtD
Esomeprazole—CYP3A4—Paclitaxel—breast cancer	0.0093	0.0217	CbGbCtD
Esomeprazole—CYP3A4—Irinotecan—breast cancer	0.00917	0.0214	CbGbCtD
Esomeprazole—CYP3A4—Vinblastine—breast cancer	0.00815	0.019	CbGbCtD
Esomeprazole—CYP3A4—Docetaxel—breast cancer	0.00672	0.0157	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—breast cancer	0.00501	0.0117	CbGbCtD
Esomeprazole—Pantoprazole—SLCO1B1—breast cancer	0.00111	0.159	CrCbGaD
Esomeprazole—Omeprazole—CYP1B1—breast cancer	0.000572	0.0817	CrCbGaD
Esomeprazole—Lansoprazole—CYP1B1—breast cancer	0.000523	0.0747	CrCbGaD
Esomeprazole—Pantoprazole—ABCG2—breast cancer	0.000484	0.0691	CrCbGaD
Esomeprazole—Rabeprazole—ABCG2—breast cancer	0.000484	0.0691	CrCbGaD
Esomeprazole—Omeprazole—ABCG2—breast cancer	0.000395	0.0563	CrCbGaD
Esomeprazole—Rabeprazole—CYP1A1—breast cancer	0.000379	0.0541	CrCbGaD
Esomeprazole—Lansoprazole—ABCG2—breast cancer	0.000361	0.0515	CrCbGaD
Esomeprazole—Omeprazole—CYP1A1—breast cancer	0.000309	0.0441	CrCbGaD
Esomeprazole—Lansoprazole—CYP1A1—breast cancer	0.000283	0.0404	CrCbGaD
Esomeprazole—Rabeprazole—CYP2D6—breast cancer	0.000282	0.0403	CrCbGaD
Esomeprazole—Pantoprazole—CYP3A4—breast cancer	0.000242	0.0346	CrCbGaD
Esomeprazole—Rabeprazole—CYP3A4—breast cancer	0.000242	0.0346	CrCbGaD
Esomeprazole—Omeprazole—CYP2D6—breast cancer	0.00023	0.0328	CrCbGaD
Esomeprazole—Lansoprazole—CYP2D6—breast cancer	0.00021	0.03	CrCbGaD
Esomeprazole—Pantoprazole—ABCB1—breast cancer	0.000201	0.0288	CrCbGaD
Esomeprazole—Omeprazole—CYP3A4—breast cancer	0.000197	0.0282	CrCbGaD
Esomeprazole—Lansoprazole—CYP3A4—breast cancer	0.00018	0.0258	CrCbGaD
Esomeprazole—Omeprazole—ABCB1—breast cancer	0.000164	0.0235	CrCbGaD
Esomeprazole—Lansoprazole—ABCB1—breast cancer	0.00015	0.0214	CrCbGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP1B1—breast cancer	4.1e-05	0.000972	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	4.09e-05	0.000971	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	4.07e-05	0.000966	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	4.07e-05	0.000966	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP1B1—breast cancer	4.04e-05	0.000959	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTA1—breast cancer	4.03e-05	0.000957	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—NAT2—breast cancer	3.99e-05	0.000946	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	3.93e-05	0.000933	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—NCOA1—breast cancer	3.91e-05	0.000927	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP19A1—breast cancer	3.85e-05	0.000914	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP19A1—breast cancer	3.8e-05	0.000901	CbGpPWpGaD
Esomeprazole—Dyspepsia—Docetaxel—breast cancer	3.74e-05	0.00013	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—breast cancer	3.73e-05	0.00013	CcSEcCtD
Esomeprazole—Insomnia—Capecitabine—breast cancer	3.72e-05	0.00013	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	3.72e-05	0.000881	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	3.72e-05	0.000881	CbGpPWpGaD
Esomeprazole—Hypoaesthesia—Doxorubicin—breast cancer	3.71e-05	0.00013	CcSEcCtD
Esomeprazole—Rash—Fluorouracil—breast cancer	3.71e-05	0.000129	CcSEcCtD
Esomeprazole—Dermatitis—Fluorouracil—breast cancer	3.71e-05	0.000129	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—breast cancer	3.7e-05	0.000129	CcSEcCtD
Esomeprazole—Paraesthesia—Capecitabine—breast cancer	3.69e-05	0.000129	CcSEcCtD
Esomeprazole—Decreased appetite—Docetaxel—breast cancer	3.69e-05	0.000129	CcSEcCtD
Esomeprazole—Hypersensitivity—Paclitaxel—breast cancer	3.69e-05	0.000129	CcSEcCtD
Esomeprazole—Headache—Fluorouracil—breast cancer	3.69e-05	0.000129	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—breast cancer	3.69e-05	0.000129	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—breast cancer	3.68e-05	0.000128	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—breast cancer	3.67e-05	0.000128	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Docetaxel—breast cancer	3.67e-05	0.000128	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—breast cancer	3.67e-05	0.000128	CcSEcCtD
Esomeprazole—Dyspnoea—Capecitabine—breast cancer	3.67e-05	0.000128	CcSEcCtD
Esomeprazole—Fatigue—Docetaxel—breast cancer	3.66e-05	0.000128	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—breast cancer	3.66e-05	0.000128	CcSEcCtD
Esomeprazole—Nausea—Mitoxantrone—breast cancer	3.65e-05	0.000127	CcSEcCtD
Esomeprazole—Nausea—Irinotecan—breast cancer	3.65e-05	0.000127	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—breast cancer	3.64e-05	0.000127	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—breast cancer	3.64e-05	0.000127	CcSEcCtD
Esomeprazole—Constipation—Docetaxel—breast cancer	3.63e-05	0.000127	CcSEcCtD
Esomeprazole—Pain—Docetaxel—breast cancer	3.63e-05	0.000127	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—breast cancer	3.63e-05	0.000127	CcSEcCtD
Esomeprazole—Dyspepsia—Capecitabine—breast cancer	3.62e-05	0.000126	CcSEcCtD
Esomeprazole—Chills—Epirubicin—breast cancer	3.62e-05	0.000126	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—breast cancer	3.6e-05	0.000125	CcSEcCtD
Esomeprazole—Asthenia—Paclitaxel—breast cancer	3.6e-05	0.000125	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—COMT—breast cancer	3.58e-05	0.00085	CbGpPWpGaD
Esomeprazole—Decreased appetite—Capecitabine—breast cancer	3.58e-05	0.000125	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—breast cancer	3.56e-05	0.000124	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GSTP1—breast cancer	3.56e-05	0.000846	CbGpPWpGaD
Esomeprazole—Nausea—Gemcitabine—breast cancer	3.56e-05	0.000124	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Capecitabine—breast cancer	3.55e-05	0.000124	CcSEcCtD
Esomeprazole—Fatigue—Capecitabine—breast cancer	3.55e-05	0.000124	CcSEcCtD
Esomeprazole—Pruritus—Paclitaxel—breast cancer	3.55e-05	0.000124	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—breast cancer	3.54e-05	0.000123	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—breast cancer	3.53e-05	0.000123	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—COMT—breast cancer	3.53e-05	0.000838	CbGpPWpGaD
Esomeprazole—Erythema multiforme—Doxorubicin—breast cancer	3.53e-05	0.000123	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HADHB—breast cancer	3.52e-05	0.000836	CbGpPWpGaD
Esomeprazole—Constipation—Capecitabine—breast cancer	3.52e-05	0.000123	CcSEcCtD
Esomeprazole—Pain—Capecitabine—breast cancer	3.52e-05	0.000123	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTP1—breast cancer	3.51e-05	0.000834	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	3.51e-05	0.000834	CbGpPWpGaD
Esomeprazole—Malnutrition—Epirubicin—breast cancer	3.51e-05	0.000122	CcSEcCtD
Esomeprazole—Feeling abnormal—Docetaxel—breast cancer	3.5e-05	0.000122	CcSEcCtD
Esomeprazole—Nausea—Fluorouracil—breast cancer	3.5e-05	0.000122	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—breast cancer	3.49e-05	0.000122	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—breast cancer	3.48e-05	0.000121	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—breast cancer	3.48e-05	0.000121	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Docetaxel—breast cancer	3.47e-05	0.000121	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—breast cancer	3.47e-05	0.000121	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—breast cancer	3.46e-05	0.000121	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—breast cancer	3.46e-05	0.000121	CcSEcCtD
Esomeprazole—Tension—Epirubicin—breast cancer	3.45e-05	0.00012	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—breast cancer	3.44e-05	0.00012	CcSEcCtD
Esomeprazole—Diarrhoea—Paclitaxel—breast cancer	3.43e-05	0.00012	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—breast cancer	3.41e-05	0.000119	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—breast cancer	3.4e-05	0.000118	CcSEcCtD
Esomeprazole—Feeling abnormal—Capecitabine—breast cancer	3.39e-05	0.000118	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—breast cancer	3.38e-05	0.000118	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—breast cancer	3.38e-05	0.000118	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—breast cancer	3.37e-05	0.000118	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—breast cancer	3.37e-05	0.000118	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Capecitabine—breast cancer	3.36e-05	0.000117	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—breast cancer	3.36e-05	0.000117	CcSEcCtD
Esomeprazole—Abdominal pain—Docetaxel—breast cancer	3.36e-05	0.000117	CcSEcCtD
Esomeprazole—Body temperature increased—Docetaxel—breast cancer	3.36e-05	0.000117	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—breast cancer	3.36e-05	0.000117	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—breast cancer	3.35e-05	0.000117	CcSEcCtD
Esomeprazole—Dizziness—Paclitaxel—breast cancer	3.31e-05	0.000116	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—breast cancer	3.31e-05	0.000115	CcSEcCtD
Esomeprazole—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.31e-05	0.000785	CbGpPWpGaD
Esomeprazole—Alopecia—Doxorubicin—breast cancer	3.3e-05	0.000115	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GSTM1—breast cancer	3.27e-05	0.000777	CbGpPWpGaD
Esomeprazole—Cough—Methotrexate—breast cancer	3.27e-05	0.000114	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—breast cancer	3.27e-05	0.000114	CcSEcCtD
Esomeprazole—Urticaria—Capecitabine—breast cancer	3.27e-05	0.000114	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—breast cancer	3.26e-05	0.000114	CcSEcCtD
Esomeprazole—Abdominal pain—Capecitabine—breast cancer	3.25e-05	0.000113	CcSEcCtD
Esomeprazole—Body temperature increased—Capecitabine—breast cancer	3.25e-05	0.000113	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—MTR—breast cancer	3.25e-05	0.000771	CbGpPWpGaD
Esomeprazole—Malnutrition—Doxorubicin—breast cancer	3.25e-05	0.000113	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—breast cancer	3.25e-05	0.000113	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTM1—breast cancer	3.23e-05	0.000766	CbGpPWpGaD
Esomeprazole—Agitation—Epirubicin—breast cancer	3.23e-05	0.000113	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FHL2—breast cancer	3.22e-05	0.000764	CbGpPWpGaD
Esomeprazole—Flatulence—Doxorubicin—breast cancer	3.2e-05	0.000112	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—breast cancer	3.19e-05	0.000111	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—breast cancer	3.19e-05	0.000111	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—breast cancer	3.19e-05	0.000111	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—breast cancer	3.19e-05	0.000111	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.19e-05	0.000756	CbGpPWpGaD
Esomeprazole—Vomiting—Paclitaxel—breast cancer	3.19e-05	0.000111	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—breast cancer	3.18e-05	0.000111	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.17e-05	0.000111	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—breast cancer	3.17e-05	0.00011	CcSEcCtD
Esomeprazole—Rash—Paclitaxel—breast cancer	3.16e-05	0.00011	CcSEcCtD
Esomeprazole—Dermatitis—Paclitaxel—breast cancer	3.16e-05	0.00011	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—breast cancer	3.16e-05	0.00011	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—breast cancer	3.16e-05	0.00011	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—breast cancer	3.15e-05	0.00011	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—breast cancer	3.14e-05	0.00011	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—breast cancer	3.14e-05	0.00011	CcSEcCtD
Esomeprazole—Headache—Paclitaxel—breast cancer	3.14e-05	0.00011	CcSEcCtD
Esomeprazole—Hypersensitivity—Docetaxel—breast cancer	3.13e-05	0.000109	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—breast cancer	3.12e-05	0.000109	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—CYP1A1—breast cancer	3.1e-05	0.000737	CbGpPWpGaD
Esomeprazole—Palpitations—Epirubicin—breast cancer	3.1e-05	0.000108	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.09e-05	0.000734	CbGpPWpGaD
Esomeprazole—Confusional state—Methotrexate—breast cancer	3.09e-05	0.000108	CcSEcCtD
Esomeprazole—Cough—Epirubicin—breast cancer	3.06e-05	0.000107	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—breast cancer	3.06e-05	0.000107	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—breast cancer	3.06e-05	0.000107	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP1A1—breast cancer	3.06e-05	0.000726	CbGpPWpGaD
Esomeprazole—Asthenia—Docetaxel—breast cancer	3.05e-05	0.000106	CcSEcCtD
Esomeprazole—Infection—Methotrexate—breast cancer	3.04e-05	0.000106	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—breast cancer	3.03e-05	0.000106	CcSEcCtD
Esomeprazole—Hypersensitivity—Capecitabine—breast cancer	3.03e-05	0.000106	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—breast cancer	3.01e-05	0.000105	CcSEcCtD
Esomeprazole—Pruritus—Docetaxel—breast cancer	3.01e-05	0.000105	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—breast cancer	3e-05	0.000105	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—breast cancer	3e-05	0.000105	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—breast cancer	3e-05	0.000105	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	2.99e-05	0.00071	CbGpPWpGaD
Esomeprazole—Chest pain—Epirubicin—breast cancer	2.99e-05	0.000104	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—breast cancer	2.99e-05	0.000104	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—breast cancer	2.99e-05	0.000104	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—breast cancer	2.99e-05	0.000104	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—breast cancer	2.98e-05	0.000104	CcSEcCtD
Esomeprazole—Nausea—Paclitaxel—breast cancer	2.98e-05	0.000104	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—breast cancer	2.97e-05	0.000104	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.97e-05	0.000104	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—breast cancer	2.96e-05	0.000103	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—breast cancer	2.95e-05	0.000103	CcSEcCtD
Esomeprazole—Asthenia—Capecitabine—breast cancer	2.95e-05	0.000103	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—breast cancer	2.93e-05	0.000102	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.93e-05	0.000694	CbGpPWpGaD
Esomeprazole—Dry mouth—Epirubicin—breast cancer	2.92e-05	0.000102	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—breast cancer	2.92e-05	0.000102	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—breast cancer	2.92e-05	0.000102	CcSEcCtD
Esomeprazole—Pruritus—Capecitabine—breast cancer	2.91e-05	0.000102	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—breast cancer	2.91e-05	0.000101	CcSEcCtD
Esomeprazole—Diarrhoea—Docetaxel—breast cancer	2.91e-05	0.000101	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	2.9e-05	0.000688	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.9e-05	0.000687	CbGpPWpGaD
Esomeprazole—Confusional state—Epirubicin—breast cancer	2.89e-05	0.000101	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.89e-05	0.000685	CbGpPWpGaD
Esomeprazole—Palpitations—Doxorubicin—breast cancer	2.87e-05	0.0001	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—breast cancer	2.87e-05	0.0001	CcSEcCtD
Esomeprazole—Infection—Epirubicin—breast cancer	2.85e-05	9.93e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP2D6—breast cancer	2.84e-05	0.000674	CbGpPWpGaD
Esomeprazole—Cough—Doxorubicin—breast cancer	2.84e-05	9.89e-05	CcSEcCtD
Esomeprazole—Shock—Epirubicin—breast cancer	2.82e-05	9.83e-05	CcSEcCtD
Esomeprazole—Diarrhoea—Capecitabine—breast cancer	2.81e-05	9.82e-05	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—breast cancer	2.81e-05	9.8e-05	CcSEcCtD
Esomeprazole—Dizziness—Docetaxel—breast cancer	2.81e-05	9.8e-05	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—breast cancer	2.81e-05	9.79e-05	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—breast cancer	2.81e-05	9.78e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.8e-05	0.000665	CbGpPWpGaD
Esomeprazole—Tachycardia—Epirubicin—breast cancer	2.8e-05	9.76e-05	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—breast cancer	2.79e-05	9.73e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.79e-05	0.000662	CbGpPWpGaD
Esomeprazole—Skin disorder—Epirubicin—breast cancer	2.78e-05	9.71e-05	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—breast cancer	2.77e-05	9.66e-05	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—breast cancer	2.77e-05	9.66e-05	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—breast cancer	2.77e-05	9.65e-05	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—breast cancer	2.77e-05	9.65e-05	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—breast cancer	2.77e-05	9.65e-05	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—breast cancer	2.76e-05	9.62e-05	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—breast cancer	2.75e-05	9.59e-05	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.75e-05	9.58e-05	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—breast cancer	2.73e-05	9.53e-05	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—breast cancer	2.73e-05	9.53e-05	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—breast cancer	2.73e-05	9.52e-05	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—breast cancer	2.72e-05	9.5e-05	CcSEcCtD
Esomeprazole—Dizziness—Capecitabine—breast cancer	2.72e-05	9.49e-05	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—breast cancer	2.71e-05	9.44e-05	CcSEcCtD
Esomeprazole—Vomiting—Docetaxel—breast cancer	2.7e-05	9.42e-05	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—breast cancer	2.7e-05	9.4e-05	CcSEcCtD
Esomeprazole—Rash—Docetaxel—breast cancer	2.68e-05	9.34e-05	CcSEcCtD
Esomeprazole—Dermatitis—Docetaxel—breast cancer	2.68e-05	9.34e-05	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—breast cancer	2.67e-05	9.33e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.67e-05	0.000633	CbGpPWpGaD
Esomeprazole—Decreased appetite—Methotrexate—breast cancer	2.66e-05	9.29e-05	CcSEcCtD
Esomeprazole—Headache—Docetaxel—breast cancer	2.66e-05	9.28e-05	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—breast cancer	2.65e-05	9.25e-05	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—breast cancer	2.64e-05	9.22e-05	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—breast cancer	2.64e-05	9.21e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.64e-05	0.000625	CbGpPWpGaD
Esomeprazole—Infection—Doxorubicin—breast cancer	2.63e-05	9.19e-05	CcSEcCtD
Esomeprazole—Pain—Methotrexate—breast cancer	2.62e-05	9.13e-05	CcSEcCtD
Esomeprazole—Vomiting—Capecitabine—breast cancer	2.62e-05	9.12e-05	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—breast cancer	2.61e-05	9.11e-05	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—breast cancer	2.61e-05	9.1e-05	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—breast cancer	2.6e-05	9.07e-05	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—breast cancer	2.6e-05	9.06e-05	CcSEcCtD
Esomeprazole—Rash—Capecitabine—breast cancer	2.59e-05	9.05e-05	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—breast cancer	2.59e-05	9.04e-05	CcSEcCtD
Esomeprazole—Dermatitis—Capecitabine—breast cancer	2.59e-05	9.04e-05	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—breast cancer	2.59e-05	9.03e-05	CcSEcCtD
Esomeprazole—Headache—Capecitabine—breast cancer	2.58e-05	8.99e-05	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—breast cancer	2.58e-05	8.98e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.58e-05	0.000611	CbGpPWpGaD
Esomeprazole—Paraesthesia—Epirubicin—breast cancer	2.57e-05	8.98e-05	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—breast cancer	2.56e-05	8.94e-05	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—breast cancer	2.56e-05	8.91e-05	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—breast cancer	2.55e-05	8.89e-05	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—breast cancer	2.53e-05	8.82e-05	CcSEcCtD
Esomeprazole—Nausea—Docetaxel—breast cancer	2.52e-05	8.8e-05	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—breast cancer	2.52e-05	8.8e-05	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—breast cancer	2.52e-05	8.8e-05	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—breast cancer	2.5e-05	8.73e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—SYNJ2—breast cancer	2.5e-05	0.000593	CbGpPWpGaD
Esomeprazole—Decreased appetite—Epirubicin—breast cancer	2.49e-05	8.69e-05	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—breast cancer	2.47e-05	8.63e-05	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—breast cancer	2.47e-05	8.62e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.46e-05	0.000584	CbGpPWpGaD
Esomeprazole—Pain—Epirubicin—breast cancer	2.45e-05	8.55e-05	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—breast cancer	2.45e-05	8.55e-05	CcSEcCtD
Esomeprazole—Nausea—Capecitabine—breast cancer	2.44e-05	8.52e-05	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—breast cancer	2.43e-05	8.49e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.43e-05	0.000576	CbGpPWpGaD
Esomeprazole—Abdominal pain—Methotrexate—breast cancer	2.42e-05	8.44e-05	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—breast cancer	2.42e-05	8.44e-05	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.42e-05	8.43e-05	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—breast cancer	2.4e-05	8.37e-05	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—breast cancer	2.38e-05	8.31e-05	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—breast cancer	2.36e-05	8.25e-05	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—breast cancer	2.36e-05	8.24e-05	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—breast cancer	2.36e-05	8.22e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.35e-05	0.000558	CbGpPWpGaD
Esomeprazole—Gastrointestinal pain—Epirubicin—breast cancer	2.34e-05	8.17e-05	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—breast cancer	2.33e-05	8.14e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—NDUFS3—breast cancer	2.32e-05	0.000551	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.32e-05	0.000549	CbGpPWpGaD
Esomeprazole—Decreased appetite—Doxorubicin—breast cancer	2.31e-05	8.04e-05	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—breast cancer	2.29e-05	7.99e-05	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—breast cancer	2.29e-05	7.97e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.28e-05	0.000542	CbGpPWpGaD
Esomeprazole—Urticaria—Epirubicin—breast cancer	2.28e-05	7.94e-05	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—breast cancer	2.27e-05	7.91e-05	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—breast cancer	2.27e-05	7.91e-05	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—breast cancer	2.27e-05	7.9e-05	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—breast cancer	2.27e-05	7.9e-05	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—breast cancer	2.26e-05	7.87e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.23e-05	0.00053	CbGpPWpGaD
Esomeprazole—Asthenia—Methotrexate—breast cancer	2.2e-05	7.66e-05	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—breast cancer	2.19e-05	7.62e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CHST9—breast cancer	2.18e-05	0.000518	CbGpPWpGaD
Esomeprazole—Gastrointestinal pain—Doxorubicin—breast cancer	2.17e-05	7.56e-05	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—breast cancer	2.17e-05	7.56e-05	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—COMT—breast cancer	2.15e-05	0.000511	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.14e-05	0.000508	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.13e-05	0.000506	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.12e-05	0.000504	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.11e-05	0.000501	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Epirubicin—breast cancer	2.11e-05	7.36e-05	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—breast cancer	2.11e-05	7.35e-05	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—breast cancer	2.1e-05	7.31e-05	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—breast cancer	2.1e-05	7.31e-05	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—breast cancer	2.1e-05	7.31e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.08e-05	0.000492	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—COX11—breast cancer	2.07e-05	0.000491	CbGpPWpGaD
Esomeprazole—Asthenia—Epirubicin—breast cancer	2.06e-05	7.17e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.04e-05	0.000483	CbGpPWpGaD
Esomeprazole—Pruritus—Epirubicin—breast cancer	2.03e-05	7.07e-05	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—breast cancer	2.03e-05	7.06e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.97e-05	0.000468	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.97e-05	0.000467	CbGpPWpGaD
Esomeprazole—Diarrhoea—Epirubicin—breast cancer	1.96e-05	6.84e-05	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—breast cancer	1.95e-05	6.81e-05	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—breast cancer	1.95e-05	6.79e-05	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.94e-05	0.000461	CbGpPWpGaD
Esomeprazole—Rash—Methotrexate—breast cancer	1.93e-05	6.73e-05	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—breast cancer	1.93e-05	6.73e-05	CcSEcCtD
Esomeprazole—Headache—Methotrexate—breast cancer	1.92e-05	6.69e-05	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—breast cancer	1.9e-05	6.64e-05	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—breast cancer	1.9e-05	6.61e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—CDA—breast cancer	1.89e-05	0.000449	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SHMT1—breast cancer	1.89e-05	0.000449	CbGpPWpGaD
Esomeprazole—Pruritus—Doxorubicin—breast cancer	1.88e-05	6.54e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.87e-05	0.000443	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.87e-05	0.000443	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.85e-05	0.000439	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.84e-05	0.000437	CbGpPWpGaD
Esomeprazole—Vomiting—Epirubicin—breast cancer	1.82e-05	6.36e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—SLC2A5—breast cancer	1.82e-05	0.000432	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLCO1B1—breast cancer	1.82e-05	0.000432	CbGpPWpGaD
Esomeprazole—Nausea—Methotrexate—breast cancer	1.82e-05	6.34e-05	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—breast cancer	1.81e-05	6.33e-05	CcSEcCtD
Esomeprazole—Rash—Epirubicin—breast cancer	1.81e-05	6.3e-05	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—breast cancer	1.81e-05	6.3e-05	CcSEcCtD
Esomeprazole—Headache—Epirubicin—breast cancer	1.8e-05	6.26e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.78e-05	0.000423	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APRT—breast cancer	1.76e-05	0.000417	CbGpPWpGaD
Esomeprazole—Dizziness—Doxorubicin—breast cancer	1.75e-05	6.12e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.73e-05	0.00041	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.72e-05	0.000408	CbGpPWpGaD
Esomeprazole—Nausea—Epirubicin—breast cancer	1.7e-05	5.94e-05	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—breast cancer	1.69e-05	5.88e-05	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—breast cancer	1.67e-05	5.83e-05	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—breast cancer	1.67e-05	5.83e-05	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—breast cancer	1.66e-05	5.79e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—ESRRA—breast cancer	1.65e-05	0.000393	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ANGPTL4—breast cancer	1.65e-05	0.000393	CbGpPWpGaD
Esomeprazole—Nausea—Doxorubicin—breast cancer	1.58e-05	5.49e-05	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.57e-05	0.000373	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPI—breast cancer	1.57e-05	0.000372	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HADHB—breast cancer	1.57e-05	0.000372	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SYNJ2—breast cancer	1.5e-05	0.000356	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.5e-05	0.000356	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH7A1—breast cancer	1.5e-05	0.000355	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH1A1—breast cancer	1.5e-05	0.000355	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.48e-05	0.000351	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ADSL—breast cancer	1.43e-05	0.00034	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UMPS—breast cancer	1.43e-05	0.00034	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PHGDH—breast cancer	1.43e-05	0.00034	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FHL2—breast cancer	1.43e-05	0.00034	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NME1—breast cancer	1.43e-05	0.00034	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—BRIP1—breast cancer	1.41e-05	0.000334	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LDHB—breast cancer	1.41e-05	0.000334	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HPSE—breast cancer	1.41e-05	0.000334	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NDUFS3—breast cancer	1.4e-05	0.000331	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA3—breast cancer	1.33e-05	0.000316	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMMR—breast cancer	1.33e-05	0.000316	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCC1—breast cancer	1.33e-05	0.000316	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CHST9—breast cancer	1.31e-05	0.000311	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARGC1B—breast cancer	1.29e-05	0.000306	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.26e-05	0.000298	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.26e-05	0.000298	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—COX11—breast cancer	1.24e-05	0.000295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA4—breast cancer	1.22e-05	0.000289	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CA9—breast cancer	1.22e-05	0.000289	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.2e-05	0.000286	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.19e-05	0.000283	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX2—breast cancer	1.19e-05	0.000282	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA2—breast cancer	1.19e-05	0.000282	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX4—breast cancer	1.17e-05	0.000279	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SULT1A1—breast cancer	1.17e-05	0.000279	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTA1—breast cancer	1.15e-05	0.000272	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—IDH1—breast cancer	1.15e-05	0.000272	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SHMT1—breast cancer	1.14e-05	0.00027	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CDA—breast cancer	1.14e-05	0.00027	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAT2—breast cancer	1.13e-05	0.000269	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.1e-05	0.00026	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A5—breast cancer	1.1e-05	0.00026	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APRT—breast cancer	1.06e-05	0.000251	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.03e-05	0.000243	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ESRRA—breast cancer	9.95e-06	0.000236	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.95e-06	0.000236	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MED12—breast cancer	9.94e-06	0.000236	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—DPYD—breast cancer	9.94e-06	0.000236	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDOA—breast cancer	9.79e-06	0.000232	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA3—breast cancer	9.5e-06	0.000225	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A2—breast cancer	9.44e-06	0.000224	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HADHB—breast cancer	9.43e-06	0.000224	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPI—breast cancer	9.43e-06	0.000224	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.34e-06	0.000222	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CPT1A—breast cancer	9.24e-06	0.000219	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCG2—breast cancer	9.24e-06	0.000219	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTR—breast cancer	9.24e-06	0.000219	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HPGDS—breast cancer	9.07e-06	0.000215	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HBA1—breast cancer	9.01e-06	0.000214	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH1A1—breast cancer	9e-06	0.000213	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH7A1—breast cancer	9e-06	0.000213	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ACHE—breast cancer	8.79e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTT1—breast cancer	8.79e-06	0.000209	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NME1—breast cancer	8.63e-06	0.000205	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FHL2—breast cancer	8.63e-06	0.000205	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ADSL—breast cancer	8.63e-06	0.000205	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PHGDH—breast cancer	8.63e-06	0.000205	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UMPS—breast cancer	8.63e-06	0.000205	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LDHB—breast cancer	8.46e-06	0.000201	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—BRIP1—breast cancer	8.46e-06	0.000201	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HPSE—breast cancer	8.46e-06	0.000201	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP17A1—breast cancer	8.32e-06	0.000197	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS1—breast cancer	8.24e-06	0.000195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ENO1—breast cancer	8.24e-06	0.000195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.21e-06	0.000195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.1e-06	0.000192	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2D6—breast cancer	8.08e-06	0.000192	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMMR—breast cancer	8.02e-06	0.00019	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA3—breast cancer	8.02e-06	0.00019	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCC1—breast cancer	8.02e-06	0.00019	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA2—breast cancer	7.93e-06	0.000188	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.77e-06	0.000184	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FASN—breast cancer	7.69e-06	0.000182	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—BCHE—breast cancer	7.66e-06	0.000182	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC5A5—breast cancer	7.57e-06	0.00018	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CA9—breast cancer	7.33e-06	0.000174	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA4—breast cancer	7.33e-06	0.000174	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A1—breast cancer	7.31e-06	0.000173	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NQO1—breast cancer	7.31e-06	0.000173	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.16e-06	0.00017	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA2—breast cancer	7.15e-06	0.00017	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX2—breast cancer	7.15e-06	0.00017	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP3A4—breast cancer	7.13e-06	0.000169	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.09e-06	0.000168	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX4—breast cancer	7.06e-06	0.000168	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SULT1A1—breast cancer	7.06e-06	0.000168	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1B1—breast cancer	7.01e-06	0.000166	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTA1—breast cancer	6.9e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—IDH1—breast cancer	6.9e-06	0.000164	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSP90AA1—breast cancer	6.87e-06	0.000163	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAT2—breast cancer	6.82e-06	0.000162	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOA1—breast cancer	6.68e-06	0.000159	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—STK11—breast cancer	6.59e-06	0.000156	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP19A1—breast cancer	6.59e-06	0.000156	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.18e-06	0.000147	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—COMT—breast cancer	6.12e-06	0.000145	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTP1—breast cancer	6.09e-06	0.000145	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—breast cancer	6.01e-06	0.000143	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ITPR1—breast cancer	6e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MED12—breast cancer	5.98e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—DPYD—breast cancer	5.98e-06	0.000142	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDOA—breast cancer	5.89e-06	0.00014	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCB1—breast cancer	5.77e-06	0.000137	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA3—breast cancer	5.71e-06	0.000136	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A2—breast cancer	5.67e-06	0.000135	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TYMS—breast cancer	5.67e-06	0.000134	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—breast cancer	5.6e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G4A—breast cancer	5.6e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NCOR1—breast cancer	5.6e-06	0.000133	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CPT1A—breast cancer	5.56e-06	0.000132	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTR—breast cancer	5.56e-06	0.000132	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCG2—breast cancer	5.56e-06	0.000132	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HPGDS—breast cancer	5.45e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HBA1—breast cancer	5.42e-06	0.000129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX1—breast cancer	5.36e-06	0.000127	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1A1—breast cancer	5.31e-06	0.000126	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ACHE—breast cancer	5.29e-06	0.000125	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTT1—breast cancer	5.29e-06	0.000125	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ERCC2—breast cancer	5.27e-06	0.000125	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP17A1—breast cancer	5.01e-06	0.000119	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ENO1—breast cancer	4.95e-06	0.000118	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS1—breast cancer	4.95e-06	0.000118	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—breast cancer	4.95e-06	0.000117	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2D6—breast cancer	4.86e-06	0.000115	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA2—breast cancer	4.77e-06	0.000113	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FASN—breast cancer	4.63e-06	0.00011	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—BCHE—breast cancer	4.61e-06	0.000109	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAV1—breast cancer	4.57e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC5A5—breast cancer	4.55e-06	0.000108	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NQO1—breast cancer	4.39e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A1—breast cancer	4.39e-06	0.000104	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.36e-06	0.000103	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1B1—breast cancer	4.21e-06	9.99e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CG—breast cancer	4.16e-06	9.87e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.13e-06	9.8e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOA1—breast cancer	4.02e-06	9.53e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—STK11—breast cancer	3.96e-06	9.4e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP19A1—breast cancer	3.96e-06	9.4e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—COMT—breast cancer	3.68e-06	8.74e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTP1—breast cancer	3.66e-06	8.7e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CD—breast cancer	3.66e-06	8.67e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—breast cancer	3.61e-06	8.58e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—breast cancer	3.61e-06	8.56e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ITPR1—breast cancer	3.61e-06	8.56e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCB1—breast cancer	3.47e-06	8.23e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—breast cancer	3.45e-06	8.19e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TYMS—breast cancer	3.41e-06	8.08e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.37e-06	7.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—breast cancer	3.37e-06	7.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NCOR1—breast cancer	3.37e-06	7.99e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX1—breast cancer	3.23e-06	7.65e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1A1—breast cancer	3.19e-06	7.57e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CB—breast cancer	3.19e-06	7.56e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ERCC2—breast cancer	3.17e-06	7.51e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—breast cancer	3.16e-06	7.49e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—breast cancer	2.98e-06	7.06e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTEN—breast cancer	2.75e-06	6.53e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAV1—breast cancer	2.75e-06	6.51e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CG—breast cancer	2.5e-06	5.93e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CD—breast cancer	2.2e-06	5.22e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—breast cancer	2.17e-06	5.15e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—breast cancer	2.08e-06	4.93e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CA—breast cancer	1.94e-06	4.61e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CB—breast cancer	1.92e-06	4.55e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—breast cancer	1.9e-06	4.5e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTEN—breast cancer	1.66e-06	3.93e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—breast cancer	1.59e-06	3.76e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CA—breast cancer	1.17e-06	2.77e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—breast cancer	9.54e-07	2.26e-05	CbGpPWpGaD
